123 related articles for article (PubMed ID: 37871880)
61. The germ-free mice monocolonization with
Lee YP; Chiu CC; Lin TJ; Hung SW; Huang WC; Chiu CF; Huang YT; Chen YH; Chen TH; Chuang HL
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):207-213. PubMed ID: 30706742
[No Abstract] [Full Text] [Related]
62. Development of a recombinant cell-based indirect immunofluorescence assay (RC-IFA) for the determination of autoantibodies against "rings and rods"-associated inosine-5'-monophosphate dehydrogenase 2 in viral hepatitis C.
Probst C; Radzimski C; Blöcker IM; Teegen B; Bogdanos DP; Stöcker W; Komorowski L
Clin Chim Acta; 2013 Mar; 418():91-6. PubMed ID: 23333419
[TBL] [Abstract][Full Text] [Related]
63. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
64. VX-497: a novel, selective IMPDH inhibitor and immunosuppressive agent.
Jain J; Almquist SJ; Shlyakhter D; Harding MW
J Pharm Sci; 2001 May; 90(5):625-37. PubMed ID: 11288107
[TBL] [Abstract][Full Text] [Related]
65. Regulation of inosine monophosphate dehydrogenase type I and type II isoforms in human lymphocytes.
Jain J; Almquist SJ; Ford PJ; Shlyakhter D; Wang Y; Nimmesgern E; Germann UA
Biochem Pharmacol; 2004 Feb; 67(4):767-76. PubMed ID: 14757177
[TBL] [Abstract][Full Text] [Related]
66. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
67. On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa.
Aherne A; Kennan A; Kenna PF; McNally N; Lloyd DG; Alberts IL; Kiang AS; Humphries MM; Ayuso C; Engel PC; Gu JJ; Mitchell BS; Farrar GJ; Humphries P
Hum Mol Genet; 2004 Mar; 13(6):641-50. PubMed ID: 14981049
[TBL] [Abstract][Full Text] [Related]
68. Assembly of IMPDH2-based, CTPS-based, and mixed rod/ring structures is dependent on cell type and conditions of induction.
Keppeke GD; Calise SJ; Chan EK; Andrade LE
J Genet Genomics; 2015 Jun; 42(6):287-99. PubMed ID: 26165495
[TBL] [Abstract][Full Text] [Related]
69. Induction of Tmolt4 leukemia cell death by 3,3-disubstituted-6,6-pentamethylene-1,5-diazabicyclo[3.1.0]hexane-2-4-diones: specificity for type II inosine 5'-monophasphate dehydrogenase.
Barnes BJ; Izydore RA; Eakin AE; Hall IH
J Pharmacol Exp Ther; 2001 Aug; 298(2):790-6. PubMed ID: 11454943
[TBL] [Abstract][Full Text] [Related]
70. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
71. Effects of inosine monophosphate dehydrogenase inhibition on high glucose-induced cellular reactive oxygen species in mesangial cells.
Song JS; Huh KH; Park J; Ju MK; Kim MS; Kim YS
Transplant Proc; 2008 Mar; 40(2):464-6. PubMed ID: 18374103
[TBL] [Abstract][Full Text] [Related]
72. ENPP2 inhibitor improves proliferation in AOM/DSS-induced colorectal cancer mice via remodeling the gut barrier function and gut microbiota composition.
Yan J; Duan W; Gao Q; Mao T; Wang M; Duan J; Li J
Pharmacol Res; 2023 Sep; 195():106877. PubMed ID: 37524154
[TBL] [Abstract][Full Text] [Related]
73. Interfilament interaction between IMPDH and CTPS cytoophidia.
Chang CC; Keppeke GD; Sung LY; Liu JL
FEBS J; 2018 Oct; 285(20):3753-3768. PubMed ID: 30085408
[TBL] [Abstract][Full Text] [Related]
74. Immune Response-Dependent Assembly of IMP Dehydrogenase Filaments.
Calise SJ; Abboud G; Kasahara H; Morel L; Chan EKL
Front Immunol; 2018; 9():2789. PubMed ID: 30555474
[TBL] [Abstract][Full Text] [Related]
75. Temporal evolution of human autoantibody response to cytoplasmic rods and rings structure during anti-HCV therapy with ribavirin and interferon-α.
Keppeke GD; Satoh M; Ferraz ML; Chan EK; Andrade LE
Immunol Res; 2014 Oct; 60(1):38-49. PubMed ID: 24845459
[TBL] [Abstract][Full Text] [Related]
76. A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.
Wang J; Zeevi A; Webber S; Girnita DM; Addonizio L; Selby R; Hutchinson IV; Burckart GJ
Pharmacogenet Genomics; 2007 Apr; 17(4):283-90. PubMed ID: 17496727
[TBL] [Abstract][Full Text] [Related]
77. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
78. Consequences of IMP dehydrogenase inhibition, and its relationship to cancer and apoptosis.
Jayaram HN; Cooney DA; Grusch M; Krupitza G
Curr Med Chem; 1999 Jul; 6(7):561-74. PubMed ID: 10390601
[TBL] [Abstract][Full Text] [Related]
79. IMPDH2 Positively Impacts the Proliferation Potential of Hepatoblastoma Cells by Activating JunB Signaling Pathway.
Yuan L; Zeng L; Ye F; Chen K; Chen Z; Li L
Curr Mol Pharmacol; 2024 Feb; ():. PubMed ID: 38676510
[TBL] [Abstract][Full Text] [Related]
80. An Optimized Protocol of Azoxymethane-Dextran Sodium Sulfate Induced Colorectal Tumor Model in Mice.
Liang X; Hu JN; He JM
Chin Med Sci J; 2019 Nov; 34(4):281-288. PubMed ID: 33906714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
